In GBM, high WWOX/HIF1A conditions leverage FAAH-mediated lipid signalling to resolve inflammation and induce tumour cell death, providing a potential mechanism for immune-mediated tumour suppression [121,153]. Here, HIF1A is linked to glioblastoma.